UNC Rex Cancer Center at Wakefield — Raleigh, North Carolina

UNC Rex Cancer Center at Wakefield is a clinical research site located in Raleigh, North Carolina, United States 27614.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

UNC Rex Cancer Center at Wakefield has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Invasive Carcinoma of the Breast, Breast Cancer.

Sponsors: Dana-Farber Cancer Institute.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UNC Rex Cancer Center at Wakefield?

UNC Rex Cancer Center at Wakefield has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UNC Rex Cancer Center at Wakefield conducted?

UNC Rex Cancer Center at Wakefield has 1 clinical trials on record, with 1 currently active. Their work covers HER2-positive Breast Cancer, Invasive Carcinoma of the Breast, Breast Cancer.

Is UNC Rex Cancer Center at Wakefield accredited by Crixeo Health?

UNC Rex Cancer Center at Wakefield has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UNC Rex Cancer Center at Wakefield?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.